Table 2. Incidence of the most common adverse events up to 1 year after transplant.
| Adverse events | Incidence of adverse events (%) | p-Value | |
|---|---|---|---|
| Everolimus | CNI | ||
| anemia | 13.92 | 8.52 | 0.004 |
| hyperlipidemia | 10.15 | 5.23 | 0.006 |
| hypercholesterolaemia | 11.11 | 5.59 | 0.01 |
| hypokalaemia | 6.25 | 1.63 | 0.02 |
| proteinuria | 8.55 | 3.53 | 0.007 |
| stomatitis | 18.04 | 1.94 | <0.00001 |
| mouth ulceration | 15.38 | 0.75 | <0.00001 |
| acne | 10.25 | 1.63 | 0.0005 |
| thrombocytopenia | 5.12 | 2.23 | 0.29 |
| cytomegalovirus | 8.90 | 11.59 | 0.11 |
| BK virus | 2.85 | 4.88 | 0.14 |
| urinary tract infection | 21.48 | 25.61 | 0.27 |
| diabetes mellitus | 4.92 | 8.29 | 0.16 |
| hypertriglyceridaemia | 2.16 | 2.51 | 0.77 |
| malignancy | 5.62 | 7.08 | 0.51 |
| cough | 6.97 | 7.35 | 0.90 |